Home › NDC Lookup › RxCUI directory › RxCUI 1006693

Sulfacetamide sodium 100 MG/ML Topical Lotion [Klaron] — RxCUI 1006693

RxNorm drug concept · Semantic branded drug
RxCUI 1006693 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1006693
Official nameSulfacetamide sodium 100 MG/ML Topical Lotion [Klaron]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKlaron 10 % Topical Lotion; Klaron (sulfacetamide sodium 10 % ) Topical Lotion; Klaron 100 MG/ML Topical Lotion
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sulfacetamide Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats conjunctivitis (pink eye) and other superficial eye infections caused by susceptible bacteria. It is also used with sulfonamide medicine given through the body for tracho...
  • You place one or two drops into the lower pocket of the affected eye. For pink eye, that's usually every two to three hours at first. Your doctor may space the doses out as you imp...
  • The most common are irritation, stinging and burning in the eye. Some people notice eye redness or a secondary infection. These are usually the things to mention to your pharmacist...
  • Stop the drops and call right away if you get a skin rash or any sign of an allergic reaction. Rarely, sulfa drugs cause serious, even fatal, reactions affecting the skin, liver or...
📖 Read our full Sulfacetamide Ophthalmic guide →

🕸️ Concept Web — How Sulfacetamide sodium 100 MG/ML Topical Lotion [K... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sulfacetamide sodium 100 MG/ML Topical Lotion [Klaron] RxCUI 1006693

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sulfacetamide 10169
    • Sulfacetamide sodium 82101
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Klaron 217903
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sulfacetamide Topical Lotion 377819
    • Sulfacetamide sodium Topical Lotion 2648184
    • Sulfacetamide Topical Product 1162338
    • Sulfacetamide sodium Topical Product 2663047
    • Sulfacetamide Topical Lotion [Klaron] 365766
    • Sulfacetamide sodium Topical Lotion [Klaron] 2655151
    • Klaron Topical Product 1171413
    • Topical Lotion 316983
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {1 (85 ML) (sulfacetamide sodium 100 MG/ML Topical Lotion) / 1 (120 ML) (urea 100 MG/ML Medicated Shampoo) } Pack 904617

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sulfacetamide sodium 100 MG/ML Topical Lotion SCD · 1006688
  • Sulfacetamide sodium 100 MG/ML SCDC · 832863
  • Sulfacetamide Topical Lotion SCDF · 377819
  • Sulfacetamide sodium Topical Lotion SCDFP · 2648184
  • Sulfacetamide Topical Product SCDG · 1162338
  • Sulfacetamide sodium Topical Product SCDGP · 2663047
  • {1 (85 ML) (sulfacetamide sodium 100 MG/ML Topical Lotion) / 1 (120 ML) (urea 100 MG/ML Medicated Shampoo) } Pack GPCK · 904617

Brand-Name Concepts

  • Sulfacetamide sodium 100 MG/ML [Klaron] SBDC · 1006692
  • Sulfacetamide Topical Lotion [Klaron] SBDF · 365766
  • Sulfacetamide sodium Topical Lotion [Klaron] SBDFP · 2655151
  • Klaron Topical Product SBDG · 1171413
  • Klaron BN · 217903

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1006693 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-5198-04 1 BOTTLE, PLASTIC in 1 CARTON (0187-5198-04) / 118 mL in 1... Klaron Bausch Health US, LLC 1996-12-23
Observed labelers: Bausch Health US, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.